NCT00404963View on ClinicalTrials.gov

A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

placebo

DRUG

GSK376501

Trial Locations (1)

47714

GSK Investigational Site, Evansville

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY